Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer

被引:116
作者
Jilg, Cordula A. [1 ]
Drendel, Vanessa [2 ]
Rischke, H. Christian [3 ,4 ]
Beck, Teresa [4 ]
Vach, Werner [5 ,6 ]
Schaal, Kathrin [1 ]
Wetterauer, Ulrich [1 ]
Schultze-Seemann, Wolfgang [1 ]
Meyer, Philipp T. [4 ,7 ]
机构
[1] Univ Freiburg, Fac Med, Med Ctr, Dept Urol, Freiburg, Germany
[2] Univ Freiburg, Fac Med, Inst Pathol, Freiburg, Germany
[3] Univ Freiburg, Fac Med, Med Ctr, Dept Radiat Oncol, Freiburg, Germany
[4] Univ Freiburg, Fac Med, Med Ctr, Dept Nucl Med, Freiburg, Germany
[5] Univ Freiburg, Fac Med, Inst Med Biometry & Stat, Freiburg, Germany
[6] Univ Freiburg, Med Ctr, Freiburg, Germany
[7] DKTK, German Canc Consortium, Partner Site Freiburg, Freiburg, Germany
关键词
prostate cancer; lymph node metastases; PSMA-PET/CT; salvage lymph node dissection; salvage lymphadenectomy; EAU GUIDELINES; PET/CT; LIGAND;
D O I
10.7150/thno.18421
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: By targeting the prostate-specific membrane antigen (PSMA) on prostate cancer (PCa) cells PSMA-PET/CT shows great potential in locating the site of biochemical recurrence even at low PSA (Prostate-specific antigen)-levels. Accurate imaging of PCa recurrent lymph node metastases (LNM) is crucial for metastases directed therapies such as salvage-lymph node dissection (salvage-LND). Objective: To evaluate the diagnostic accuracy of PSMA-PET/CT for detection of affected lymph-node regions at salvage-LND for nodal recurrence of PCa. Design, setting and participants: 30 patients with the suspicion of exclusively nodal PCa-relapse after primary therapy underwent a template pelvic and/or retroperitoneal salvage-LND after whole body 68-Ga-PSMA-PET/CT. The diagnostic accuracy of PET/CT was evaluated in comparison to the histopathology of 965 resected lymph nodes (LN) dissected from 68 main regions (pelvic left/right, retroperitoneal) and 289 subregions (common iliac, external iliac, obturator, internal iliac, presacral, aortic-bifurcation, aortal, caval). LNM and tumor deposits in LNM were measured bidimensionally in the histopathology. PSMA-expression was analyzed by immunohistochemistry in LNM. Results: LNM were present in 11.4% of the resected LN (110/965) resulting in 45 positive main regions and 85 positive subregions. PET/CT was true positive in 41 main regions and 69 subregions. Three PET-negative main regions and 16 PET-negative subregions finally contained LNM, the majority of these false negative subregions (13/16) were in neighboring regions of true-positive subregions. Sensitivity, specificity, positive predictive value, negative predictive value and accuracy were: main region-based 93.2%, 100%, 100%, 88.9% and 95.6%, subregion-based 81.2%, 99.5%, 98.6%, 92.7 and 94.1%. Median short diameters of tumor deposits in LNM resected from false-negative subregions (1.3 mm) were significantly smaller than in LNM removed from true-positive subregions (5.5 mm, p<0.0001). Based on anatomical subregions containing just one LNM, the necessary short diameter of tumor deposits in LNM required to reach a detection rate of 50% and 90% was estimated to be >= 2.3 mm and >= 4.5 mm, respectively. Conclusion: In men with biochemical PCa-relapse and positive PSMA-PET/CT, PET/CT detects metastatic affected anatomical regions with high accuracy at a main region and at a subregion-level. If the decision for salvage-LND is prompted by a positive PSMA-PET/CT, the size of metastases is crucial for accurate detection of affected regions. All LNM showed a clear PSMA-expression in the immunohistochemistry. Further studies need to investigate how to translate the high anatomical correlation observed between PET/CT and surgical findings into optimal approaches for target salvage-LND.
引用
收藏
页码:1770 / 1780
页数:11
相关论文
共 23 条
[1]   PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions [J].
Afshar-Oromieh, A. ;
Malcher, A. ;
Eder, M. ;
Eisenhut, M. ;
Linhart, H. G. ;
Hadaschik, B. A. ;
Holland-Letz, T. ;
Giesel, F. L. ;
Kratochwil, C. ;
Haufe, S. ;
Haberkorn, U. ;
Zechmann, C. M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (04) :486-495
[2]  
Afshar-Oromieh A, 2014, EUR J NUCL MED MOL I
[3]   Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer [J].
Afshar-Oromieh, Ali ;
Zechmann, Christian M. ;
Malcher, Anna ;
Eder, Matthias ;
Eisenhut, Michael ;
Linhart, Heinz G. ;
Holland-Letz, Tim ;
Hadaschik, Boris A. ;
Giesel, Frederik L. ;
Debus, Juergen ;
Haberkorn, Uwe .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (01) :11-20
[4]   Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy [J].
Budaeus, Lars ;
Leyh-Bannurah, Sami-Ramzi ;
Salomon, Georg ;
Michl, Uwe ;
Heinzer, Hans ;
Huland, Hartwig ;
Graefen, Markus ;
Steuber, Thomas ;
Rosenbaum, Clemens .
EUROPEAN UROLOGY, 2016, 69 (03) :393-396
[5]   Gleason Score at Diagnosis Predicts the Rate of Detection of 18F-Choline PET/CT Performed When Biochemical Evidence Indicates Recurrence of Prostate Cancer: Experience with 1,000 Patients [J].
Cimitan, Marino ;
Evangelista, Laura ;
Hodolic, Marina ;
Mariani, Giuliano ;
Baseric, Tanja ;
Bodanza, Valentina ;
Saladini, Giorgio ;
Volterrani, Duccio ;
Cervino, Anna Rita ;
Gregianin, Michele ;
Puccini, Giulia ;
Guidoccio, Federica ;
Fettich, Jure ;
Borsatti, Eugenio .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (02) :209-215
[6]  
Deutsche Krebsgesellschaft DK AWMF, 2016, KONS INT LEITL QUAL
[7]   Novel Preclinical and Radiopharmaceutical Aspects of [Ga-68]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer [J].
Eder, Matthias ;
Neels, Oliver ;
Mueller, Miriam ;
Bauder-Wust, Ulrike ;
Remde, Yvonne ;
Schaefer, Martin ;
Hennrich, Ute ;
Eisenhut, Michael ;
Afshar-Oromieh, Ali ;
Haberkorn, Uwe ;
Kopka, Klaus .
PHARMACEUTICALS, 2014, 7 (07) :779-796
[8]   Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy [J].
Eiber, Matthias ;
Maurer, Tobias ;
Souvatzoglou, Michael ;
Beer, Ambros J. ;
Ruffani, Alexander ;
Haller, Bernhard ;
Graner, Frank-Philipp ;
Kuebler, Hubert ;
Haberhorn, Uwe ;
Eisenhut, Michael ;
Wester, Hans-Juergen ;
Gschwend, Juergen E. ;
Schwaiger, Markus .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (05) :668-674
[9]   EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer [J].
Heidenreich, Axel ;
Bastian, Patrick J. ;
Bellmunt, Joaquim ;
Bolla, Michel ;
Joniau, Steven ;
van der Kwast, Theodor ;
Mason, Malcolm ;
Matveev, Vsevolod ;
Wiegel, Thomas ;
Zattoni, Filiberto ;
Mottet, Nicolas .
EUROPEAN UROLOGY, 2014, 65 (02) :467-479
[10]   EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent-Update 2013 [J].
Heidenreich, Axel ;
Bastian, Patrick J. ;
Bellmunt, Joaquim ;
Bolla, Michel ;
Joniau, Steven ;
van der Kwast, Theodor ;
Mason, Malcolm ;
Matveev, Vsevolod ;
Wiegel, Thomas ;
Zattoni, F. ;
Mottet, Nicolas .
EUROPEAN UROLOGY, 2014, 65 (01) :124-137